NFKB1 and COVID-19: Because NF-κB and NF-κB-dependent IL-6 are major actors in the COVID-19-associated cytokine storm and high IL-6 levels worsen prognosis and predicts mortality (13, 17, 35, 41), drugs that can block this pathway are of immediate interest (18–21, 42–44).